NovaBay Pharmaceuticals Inc’s wound cleanser NeutroPhase achieved better results in lab tests, killing bacteria in less than a minute Feb 18, 2014 (Menafn – M2 EQUITYBITES via COMTEX) –Biopharmaceutical company NovaBay Pharmaceuticals Inc (nyse mkt:NBY) stated on Monday that its wound cleanser, NeutroPhase, has achieved better results in lab tests than 18 other commercial products.…

Read More

NovaBay’s NeutroPhase┬« is Best in Class in Laboratory Study of 19 Top Commercial Wound Cleansers The In Vitro Study, Published in the Peer-Reviewed Journal Advances in Skin & Wound Care, Showed that NeutroPhase┬« Kills Bacteria Quickly Among the Products Tested, NeutroPhase Offered the Best Activity Against Microbes at Concentrations Safe to Mammalian Cells EMERYVILLE, Calif.,…

Read More